YZYuqing Mm Zhu

Yuqing Mm Zhu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yuqing Mm Zhu has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Chenlu Shen

    The First Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, China

    1 shared publication
  • Jie Hu

    School of Public Health, Hebei Medical University, Shijiazhuang, China

    1 shared publication
  • Kaihan Wu

    Department of Gastroenterology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China

    1 shared publication
  • Keying Du

    The First Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, China

    1 shared publication
  • Qi-Cong Li

    Department of Vascular Surgery, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China

    1 shared publication
  • Qiang Chen

    Department of Neurology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), The First Clinical College of Zhejiang Chinese Medical University, Hangzhou, China

    1 shared publication

Latest Publications

  • Open Access

    Association of circulating visfatin level and metabolic fatty liver disease: An updated meta-analysis and systematic review

    by Shuaihang Chen, Kaihan Wu, Yani Ke, Shanshan Chen, Ran He, Qin Zhang, Chenlu Shen, Qicong Li, Yuting Ruan, Yuqing Zhu, et al.

    Background: The rate of incidence of metabolic dysfunction-related fatty liver disease (MAFLD) has rapidly increased globally in recent years, but early diagnosis is still a challenge. The purpose of this systematic review and meta-analysis is to identify visfatin for early diagnosis of MAFLD. Methods: We strictly adhered to the relevant requirements of Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The systematic search was conducted in 7 sources (PubMed, Embase, Cochrane Library, CNKI, Wanfang, CBM, and ClinicalTrials.gov) until February 2024. The meta-analysis was performed using Stata 12. Outcomes were expressed in the form of standardized mean difference (SMD) and 95% confidence interval and were analyzed using meta-analysis. Results: The results showed that there was no significant difference in circulating visfatin levels between patients with MAFLD and controls (SMD = 0.13 [−0.34, 0.60]). However, the outcomes indicated that the level of circulating visfatin was significantly higher in MAFLD patients in the Middle Eastern subgroup (SMD = 0.45 [0.05, 0.85]) and in the obese patient subgroup (SMD = 1.05 [0.18, 1.92]). No publication bias was detected, and sensitivity analysis confirmed the stability of the outcomes. Conclusion: The serum visfatin levels of MAFLD patients did not differ significantly from those of controls. However, visfatin concentrations in serum were statistically higher within Middle Eastern or obese MAFLD patients compared to controls. There is a need for further research to investigate visfatin’s potential as a biomarker for MAFLD.


  • Open Access

    A relatively rare traditional Chinese medicine pattern of primary Sjögren syndrome: A case report

    by Qiang Chen, Xinru Mm Chen, Yuqing Mm Zhu, Xiali Mm Yu

    Rationale: This report presents a unique case of a patient diagnosed with Primary Sjögren’s syndrome and a relatively rare traditional Chinese medicine pattern, known as the combined cold and heat pattern and cold-dampness syndrome. The patient’s condition was successfully managed using Chinese herbal medicine, specifically the modified Da-Chai-Hu decoction and Linggui Zhugan decoction. Patient concerns: A 56-year-old woman had chronic dry eye and mouth for over 10 years. She was initially managed with traditional Chinese herbal medicine (TCHM) prescriptions, including the Zengye decoction, but the therapeutic effects were unsatisfactory. As the disease progressed, she was diagnosed with an anxiety disorder due to symptoms of vexation and insomnia. Treatment with alprazolam and venlafaxine failed to alleviate these symptoms. Recently, her general condition gradually worsened, with symptoms including a bitter taste in her mouth, dizziness, hot flashes, chills, poor appetite, chest discomfort, and constipation. Diagnoses: After a series of examinations, including a Schirmer test and labial gland biopsy, she was diagnosed with Sjögren’s syndrome. Interventions: Despite regular treatment with pilocarpine, sodium hyaluronate eye drops, venlafaxine, and alprazolam, the dry mouth symptoms intensified. Consequently, she sought further intervention through the TCHM. Outcomes: After 8 weeks of treatment with the modified Da-Chai-Hu decoction and Linggui Zhugan decoction, she reported a significant improvement in her dryness-related symptoms and sleep quality. Lessons: This case report demonstrates that TCHM can effectively treat Primary Sjögren’s syndrome, and should be considered for broader applications. Furthermore, this underscores the importance of tailoring treatment formulas to patients by identifying their specific syndrome differentiation in a clinical setting.